Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study
about
Translating the MAM model of psychosis to humansIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaImaging glutamate in schizophrenia: review of findings and implications for drug discovery.Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.Glutamate-mediated excitotoxicity in schizophrenia: a review.Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiationIn vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS StudiesBrain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature.Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in SchizophreniaRelationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophreniaMedial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression studyAbnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone.Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia.Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 TeslaTreatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task.Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory.Glutamate and dopamine in schizophrenia: an update for the 21st centuryReduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh RiskElevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study.Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system.The neurobiology and treatment of first-episode schizophrenia.Antipsychotic treatment modulates glutamate transport and NMDA receptor expression.Glutamatergic agents for schizophrenia: current evidence and perspectives.The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review.Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.Increased glutamate/GABA+ ratio in a shared autistic and schizotypal trait phenotype termed Social Disorganisation.Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.
P2860
Q26860217-D3056A55-92D9-4060-9516-2131DA501F9EQ28083121-4B3AB653-88A5-4096-ACFC-6222FEDEDD7EQ30685335-FB35442B-8B18-4F4A-A868-3EA61F6E8ADFQ30686416-E7515774-5EB3-42E9-9E44-9BB4913BE583Q30712278-4532C9B4-9DD7-4D22-B731-B4193C89D806Q30732395-99DED370-9146-40AA-9245-95E286F70134Q30845062-1E6A593B-7135-4E38-B775-0DC5FE60E45CQ30854782-C179161B-5E11-4603-89F5-FD14F1723BF8Q30873588-435A5E7E-A56C-4BEF-B290-1F02589C9A10Q30993265-A5A93647-A4E8-43CC-AB0E-C031E5B29C64Q33604654-7293BE17-F044-4428-9F0A-D881B405DD41Q33611412-7A6CC11B-FD90-4D8C-8A96-22ED905D6D33Q33718818-3D9E8A3B-FF77-4C3B-B51F-23F35F2ACDF6Q33785717-71EE9B5F-75EA-45E9-AFED-DECDE6B2CAAAQ34270086-C11E3F38-0512-4CD1-885B-BA69174D26C0Q34446463-10ADC58C-5CCF-473F-9BCB-9B3112A27760Q34579973-5C56D7AE-D216-4F5F-B953-24BED6D6B849Q35626964-CB94005A-3BF7-44C3-A7EE-886814E334EAQ36113065-598A6920-9BA2-4176-B953-67B5012E3196Q36382573-0313B8C9-A4DC-46B3-B801-0F4797C3DF9EQ36575926-43FB4A03-986D-4B57-9863-0530CB75FAA1Q36579965-AD12840C-8A27-4250-9B99-136136137BF8Q36579976-C3219BA7-ACB0-4F20-A80F-90ED8F07424BQ36767551-F7834437-9436-4169-AF6A-4A25E4EF41B4Q36817154-4CD3A911-D99E-4CD6-9FE8-DC89ED722ACFQ36848303-F19C9AFE-E737-4873-BFE6-A37B515A53BAQ36983379-6F04D244-B735-4AA7-8BF9-E94DB377BAF6Q36992322-8FB4B235-4ECD-41CA-8432-76648A612A85Q37492603-E9AA84D1-692F-423B-A9AC-C04F2F068D0DQ37622674-D03BF47D-0F3C-491D-9941-DF9F2269EB02Q38207021-546C3877-DC92-4D23-9DF7-9C9E03D14B21Q38232366-67BC3453-E9A5-45E7-A19F-6C3626014E5AQ38248566-BEA86F4A-59BF-4EF8-B47D-1DCCB9EFCCFDQ38444551-29213C4E-3C3F-4087-8D70-D379B68767C1Q38579616-B4FE5AF2-FA93-4C53-A220-4096C6465793Q39464596-57089D4F-4CFB-4273-B60C-80E7B6065711Q41192636-8F5B881D-C9D9-4B14-89BC-BAFA956A083FQ41724967-CC3DDEDD-CA18-4F81-BE4C-106F5DFB5B25Q43538712-41824014-F117-4329-A051-6C5CF6EDBF4BQ44560334-9BB14DEF-90E4-45B6-A733-41A6DAF6C04E
P2860
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glutamate levels in the associ ...... c resonance spectroscopy study
@en
Glutamate levels in the associ ...... resonance spectroscopy study.
@nl
type
label
Glutamate levels in the associ ...... c resonance spectroscopy study
@en
Glutamate levels in the associ ...... resonance spectroscopy study.
@nl
prefLabel
Glutamate levels in the associ ...... c resonance spectroscopy study
@en
Glutamate levels in the associ ...... resonance spectroscopy study.
@nl
P2093
P2860
P50
P1433
P1476
Glutamate levels in the associ ...... c resonance spectroscopy study
@en
P2093
Camilo de la Fuente-Sandoval
Jesús Ramírez-Bermúdez
Leonardo Díaz-Galvis
Mariana Azcárraga
Pablo León-Ortiz
Patricia Alvarado-Alanis
Rafael Favila
Sylvana Stephano
P2860
P304
P356
10.1001/JAMAPSYCHIATRY.2013.289
P407
P577
2013-10-01T00:00:00Z